Impact Series 3: Nanoworx. Smart Optimization for Scale-Up Makes the Difference
June 25, 2025

In the PharmaNL Impact Series, we spotlight innovative projects that have taken off thanks to funding from PharmaNL. What are the initial results? What challenges have emerged? And what can others learn from these experiences? In this third episode, we take a closer look at Nanoworx, a promising initiative within the PharmaNL program line Shared […]

Impact Series 2: iPsomics. From Academic Innovation to Personalized Cancer Treatment
June 19, 2025

The PharmaNL Impact Series showcases real-life examples of how PharmaNL projects are progressing. What early results are emerging, what challenges are being faced, and what lessons can others take from them? In this second episode, we caught up with Peter Ketelaar and Floris Foijer of iPsomics, a promising life science start-up born out of the […]

English Translation of Investment Agenda Part 3 Now Available
June 12, 2025

The English translation of PharmaNL Investment Agenda Part 3 is now available. This document, part of the agenda presented on 22 August 2024, focuses on the Shared Development Infrastructure programme line. The Investment Agenda serves as a roadmap for targeted investments aimed at strengthening the Dutch pharmaceutical value chain.

terugblik
From Pitch to Partnership: PharmaNL Connection Days 2025
April 16, 2025

Three rooms filled with engaged professionals, exchange, and ideas shaping the future of the pharmaceutical sector—that was the outcome of the PharmaNL Connection Days in March and April 2025. The central theme was to stimulate project applications for the Shared Development Infrastructure (SDI) subsidy call, which opened on March 18. Floor van de Watering, program […]

Opening PharmaNL SDI subsidy call on March 18, 2025
March 18, 2025

ZonMw, the subsidy administrator of PharmaNL, opens a subsidy call within the PharmaNL Shared Development Infrastructure program on Tuesday, March 18, 2025. The objective of this subsidy call is to address the prioritized themes from PharmaNL’s investment agenda. View this investment agenda, published on January 30, 2025, here. Read the full news article about the […]

vooraankondiging
Pre-announcement PharmaNL Shared Development Infrastructure 2025
February 11, 2025

Great news! ZonMw, the managing organization of the PharmaNL subsidy program, is planning to launch a subsidy call for the PharmaNL Shared Development Infrastructure program on Tuesday, March 18, 2025! This subsidy supports the construction and upgrading of advanced infrastructure for pharmaceutical startups, scale-ups, and academic research groups. It’s a unique opportunity to collaborate and […]

investeringsagenda shared
PharmaNL publishes Investment Agenda for Shared Development Infrastructure
January 30, 2025

PharmaNL today publishes the Investment Agenda for the Shared Development Infrastructure program line. This document (part 3) is an integral part of the PharmaNL investment agenda as presented on August 22, 2024, focusing on the Human Capital Growth program line. The Investment Agenda serves as a roadmap for investments aimed at strengthening the Dutch pharmaceutical […]

G2Solutions: Funding for Innovation in Single-Cell Genomics
September 17, 2024

The G2Solutions project, led by Prof. Dr. Ir. Floris Foijer from the UMCG – ERIBA Research Institute, has received funding from PharmaNL under the PharmaNL Shared Development Infrastructure program for their five-year project. G2Solutions focuses on developing infrastructure for new drug development. “This project demonstrates that we can make unique technologies, such as single-cell sequencing […]

Nanoworx
Second Project Funding Round of PharmaNL Shared Development Infrastructure Launches
September 12, 2024

The project “Nanoworx,” led by Prof. Dr. Willem Mulder, will soon commence under the PharmaNL Shared Development Infrastructure program. Projects in this program aim to establish infrastructure provisions for groundbreaking pharmaceutical products and drug development technologies.

First Project Funding Round of PharmaNL Shared Development Infrastructure Launches
August 15, 2024

In the coming months, the first project ‘G2 Solutions’ will start under the leadership of Prof. Dr. Ir. Floris Foijer within the PharmaNL Shared Development Infrastructure program line. Projects within this program focus on establishing infrastructure provisions for groundbreaking pharmaceutical products and technologies for drug development. Objective of the Funding Round The PharmaNL Shared Development […]